Page 5 - Exscientia News Today

Exscientia (NASDAQ:EXAI – Get Rating) is scheduled to be announcing its earnings results before the market opens on Wednesday, May 24th. Exscientia (NASDAQ:EXAI – Get Rating) last posted its earnings results on Thursday, March 23rd. The company reported ($0.38) EPS for the quarter. The business had revenue of $8.20 million during the quarter, compared to […]

Exscientia (NASDAQ:EXAI – Get Rating) and Palisade Bio (NASDAQ:PALI – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Earnings & Valuation This table compares Exscientia and Palisade Bio’s […]

Exscientia plc (NASDAQ:EXAI – Get Rating) was up 8.8% during mid-day trading on Monday . The stock traded as high as $5.77 and last traded at $5.69. Approximately 110,254 shares were traded during trading, a decline of 63% from the average daily volume of 302,019 shares. The stock had previously closed at $5.23. Wall Street […]

Changing the world through exceptional science and technology Professor Andrew Hopkins DPhil LLD FRSE, founder and Chief Executive of Exscientia plc (Nasdaq: EXAI), has been elected a Fellow of the

- Renowned thought leader in computational biology and data science for cancer research - - Over 180 publications on the evolutionary dynamics of cancer initiation, progression, response to therapy

-- Winners to be Announced and Recognised on 11 May at the Prix Galien UK Awards Ceremony in London LONDON, May 2, 2023 /PRNewswire/ -- The Galien Foundation, the premier global institution

Exscientia plc (NASDAQ:EXAI – Get Rating)’s stock price traded down 4.5% during mid-day trading on Friday . The company traded as low as $5.57 and last traded at $5.68. 107,689 shares changed hands during mid-day trading, a decline of 67% from the average session volume of 329,902 shares. The stock had previously closed at $5.95. […]

Includes recent advancements from precision designed compounds Functional personalised medicine platform unveiling unique adenosine biomarker to enrich for patients more likely to respond to treatment

Exscientia (NASDAQ:EXAI – Get Rating) had its price objective reduced by Morgan Stanley from $15.00 to $14.00 in a research note issued to investors on Monday, Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock. Exscientia Stock Up 7.0 % Shares of NASDAQ:EXAI opened at $5.68 on Monday. The company has […]

City spokesperson Lindela Mashigo said the flooding occurred when the water utility was fixing a major water leak on the B8 pipeline from Zuikerbosch water treatment plant to the Mapleton booster pumping station on Wednesday